In the second of the CAV sponsored Research In Practice Grants recently approved, Dr Lorna Hardy will investigate the effect diarrhoea has on the cardiovascular system with the aim of treating patients more effectively.

HPNZ has just approved two new research projects under the CAV sponsored Research in Practice Grant category. The first of these is a study to be undertaken by Dr Joon Seo on Feline Cardiomyopathy, a common heart disease in cats that is poorly understood and has no specific treatment.

Research is what allows us to make advancements in veterinary medicine and improve our care of our furry companions. Healthy Pets New Zealand has funded over 30 studies which have benefited the NZ veterinary community and the animals we treat.

Southlanders and the weather came to the party to make the first ever HPNZ Dogs’ Day Out – a celebration of all things canine – a great success, despite a move to Covid Alert level 2 only 12 hours before kick-off.

Recently published research funded by Healthy Pets New Zealand has shown that the Fel-O-Vax FIV vaccine against Feline Immunodeficiency Virus (FIV) does not prevent infection with the virus in NZ. Given the lack of significant protection against FIV infection and the uncertainty regarding whether or not FIV infection causes disease, there is currently little scientific evidence supporting the use of this vaccine in New Zealand.

HPNZ Trustee and researcher Prof. John Munday has been awared a Doctor of Science, one of the highest academic accolades, at Massey University's Manawatū 2021 graduation ceremony for his ongoing research into animal cancer

The Companion Animal Veterinarians branch (CAV) of the New Zealand Veterinary Association has signed an agreement to become Healthy Pets New Zealand’s first Research in Practice Partner.

Premium pet food manufacturer Royal Canin is the first Healthy Pets New Zealand Human-Animal Bond Partner.